![]() ![]() Atrioventricular nodal reentrant tachycardia. Contemporary management of atrial flutter. Calcium and cardiac rhythms: physiological and pathophysiological. Early afterdepolarizations and cardiac arrhythmias. Weiss JN, Garfinkel A, Karagueuzian HS, Chen PS, Qu Z. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J. Genesis and regulation of the heart automaticity. Excitation-contraction coupling and cardiac contractile force. doi: 10.1038/415198a Crossref Medline Google Scholar doi: 10.1186/s42822-3 Crossref Medline Google Scholar A comparative review on heart ion channels, action potentials and electrocardiogram in rodents and human: extrapolation of experimental insights to clinic. doi: 10.1007/BF00798257 Crossref Medline Google Scholar Ionic currents and action potentials in rabbit, rat, and guinea pig ventricular myocytes. Varró A, Lathrop DA, Hester SB, Nánási PP, Papp JG. Cardiac transmembrane ion channels and action potentials: cellular physiology and arrhythmogenic behavior. ![]() Varró A, Tomek J, Nagy N, Virág L, Passini E, Rodriguez B, Baczkó I. Cardiac electrophysiology: from cell to bedside. Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3. Mazzanti A, Maragna R, Faragli A, Monteforte N, Bloise R, Memmi M, Novelli V, Baiardi P, Bagnardi V, Etheridge SP, et al. doi: 10.1001/jamacardio.2017.1320 Crossref Medline Google Scholar Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial. Kannankeril PJ, Moore JP, Cerrone M, Priori SG, Kertesz NJ, Ro PS, Batra AS, Kaufman ES, Fairbrother DL, Saarel EV, et al. Analysis of interectopic activation patterns during sustained ventricular tachycardia. Brachmann J, Kabell G, Scherlag B, Harrison L, Lazarra R. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, Wu TJ, Czer L, Wolf PL, Denton TA, Shintaku IP, et al. Cardiac fibrosis as a determinant of ventricular tachyarrhythmias. Morita N, Mandel WJ, Kobayashi Y, Karagueuzian HS. The prognostic significance of cardiac structure and function in atrial fibrillation: The ENGAGE AF-TIMI 48 echocardiographic substudy. Gupta DK, Giugliano RP, Ruff CT, Claggett B, Murphy S, Antman E, Mercuri MF, Braunwald E, Solomon SD Effective Anticoagulation with Factor Xa Next Generation in AFTiMIESI. Overview of basic mechanisms of cardiac arrhythmia. Biology of cardiac arrhythmias: ion channel protein trafficking. ![]() Delisle BP, Anson BD, Rajamani S, January CT. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. V TORRENTE LS MODELS TRIALCardiac Arrhythmia Suppression Trial III. the cardiac arrhythmia suppression trial. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL. Frequency of cardiac rhythm abnormalities in a half million adults. Khurshid S, Choi SH, Weng LC, Wang EY, Trinquart L, Benjamin EJ, Ellinor PT, Lubitz SA.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |